Spleen colony studies of leukemia L1210. 3. Differential sensitivities of normal hematopoietic and resistant L1210 colony-forming cells to 6-mercaptopurine (NSC-755) - PubMed (original) (raw)
- PMID: 5646852
Spleen colony studies of leukemia L1210. 3. Differential sensitivities of normal hematopoietic and resistant L1210 colony-forming cells to 6-mercaptopurine (NSC-755)
I Wodinsky et al. Cancer Chemother Rep. 1968 Feb.
No abstract available
Similar articles
- Chemotherapy of leukemia L1210 by 6-mercaptopurine (NSC-755) in combination with 6-methylthiopurine ribonucleoside (NSC-40774).
Schabel FM Jr, Laster WR Jr, Skipper HE. Schabel FM Jr, et al. Cancer Chemother Rep. 1967 Jun;51(3):111-24. Cancer Chemother Rep. 1967. PMID: 6043734 No abstract available. - Spleen colony studies of leukemia L1210. IV. Sensitivities of L1210 and L1210/6-MP to triazenoimidazolecarboxamides--a preliminary report.
Wodinsky I, Swiniarski J, Kensler CJ. Wodinsky I, et al. Cancer Chemother Rep. 1968 Apr;52(3):393-8. Cancer Chemother Rep. 1968. PMID: 5670721 No abstract available. - Combined therapy of L1210 leukemia with Damvar and cytostatics.
Pujman V, Cernochová S. Pujman V, et al. Neoplasma. 1979;26(5):521-3. Neoplasma. 1979. PMID: 522924 - Anti leukemia activity (L1210) of 6-mercaptopurine and its metallo complexes in mice.
Skinner SM, Lewis RW. Skinner SM, et al. Res Commun Chem Pathol Pharmacol. 1977 Jan;16(1):183-6. Res Commun Chem Pathol Pharmacol. 1977. PMID: 841179
Cited by
- Prospective identification of tumorigenic breast cancer cells.
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Al-Hajj M, et al. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8. doi: 10.1073/pnas.0530291100. Epub 2003 Mar 10. Proc Natl Acad Sci U S A. 2003. PMID: 12629218 Free PMC article. - Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?
Passegué E, Jamieson CH, Ailles LE, Weissman IL. Passegué E, et al. Proc Natl Acad Sci U S A. 2003 Sep 30;100 Suppl 1(Suppl 1):11842-9. doi: 10.1073/pnas.2034201100. Epub 2003 Sep 22. Proc Natl Acad Sci U S A. 2003. PMID: 14504387 Free PMC article. Review. - Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.
Valdivielso JM, Balafa O, Ekart R, Ferro CJ, Mallamaci F, Mark PB, Rossignol P, Sarafidis P, Del Vecchio L, Ortiz A. Valdivielso JM, et al. Drugs. 2021 Sep;81(13):1467-1489. doi: 10.1007/s40265-021-01555-5. Epub 2021 Jul 27. Drugs. 2021. PMID: 34313978 Review. - Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population.
Steiniger SC, Coppinger JA, Krüger JA, Yates J 3rd, Janda KD. Steiniger SC, et al. Stem Cells. 2008 Dec;26(12):3037-46. doi: 10.1634/stemcells.2008-0397. Epub 2008 Sep 18. Stem Cells. 2008. PMID: 18802034 Free PMC article. - Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications.
Kelly SE, Di Benedetto A, Greco A, Howard CM, Sollars VE, Primerano DA, Valluri JV, Claudio PP. Kelly SE, et al. PLoS One. 2010 Apr 8;5(4):e10035. doi: 10.1371/journal.pone.0010035. PLoS One. 2010. PMID: 20386701 Free PMC article.